{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:56:44Z","timestamp":1753869404174,"version":"3.41.2"},"reference-count":38,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Foot and Ankle Research"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Diabetic foot ulcers (DFUs) are commonly contaminated with pathogenic organisms and precede most diabetes\u2010related amputations. Antimicrobial dressings are used in the treatment of DFUs; however, recent guidelines do not support their use. There are no data describing the experience of antimicrobial dressing use among podiatrists in Aotearoa New Zealand (AoNZ). This study aimed to (i) determine which antimicrobial dressings podiatrists in AoNZ use for the management of diabetic foot ulcers; and (ii) determine what factors influence AoNZ podiatrists' use of antimicrobial dressing when managing DFUs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An anonymous cross\u2010sectional web\u2010based survey was undertaken. Participants were AoNZ registered podiatrists who managed DFUs in their practice. The survey included questions relating to personal and professional demographic characteristics and DFU management and dressing practices. Descriptive statistics were computed to address the research aims.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Responses from 43 AoNZ podiatrists were included. Participants reported both cadexomer iodine and silver dressings were the most common antimicrobial dressings used, with honey dressings being the least frequently used. The most influential factors in choosing antimicrobial dressings when managing DFUs were the presence of current infection, ulcer exudate and ability to prevent future infection. The least influential factors in choosing antimicrobial dressings when managing DFUs were patient preferences, cost of dressings and comfort of dressing\/pain on removal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AoNZ podiatrists managing DFUs primarily use antimicrobial dressings containing cadexomer iodine or silver as active ingredients, while lower\u2010cost options, such as honey and povidone iodine are less often used. Current recommendations highlight the lack of evidence to support positive outcomes from any particular antimicrobial dressing over another and advocate that exudate control, comfort and cost be prioritised in decision\u2010making. As cost has been an increasing burden to our healthcare funding, clinicians and organisations may consider this before purchasing and stocking expensive dressings.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jfa2.12032","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T12:25:34Z","timestamp":1718627134000},"source":"Crossref","is-referenced-by-count":0,"title":["The use of antimicrobial dressings for the management of diabetic foot ulcers: A survey of podiatrists in Aotearoa New Zealand"],"prefix":"10.1002","volume":"17","author":[{"given":"Skye","family":"Ma","sequence":"first","affiliation":[{"name":"School of Clinical Sciences Faculty of Health and Environmental Sciences Auckland University of Technology  Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Frecklington","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences Faculty of Health and Environmental Sciences Auckland University of Technology  Auckland New Zealand"},{"name":"Active Living and Rehabilitation: Aotearoa New Zealand Health and Rehabilitation Research Institute School of Clinical Sciences Auckland University of Technology  Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9318-5627","authenticated-orcid":false,"given":"Sarah","family":"Stewart","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences Faculty of Health and Environmental Sciences Auckland University of Technology  Auckland New Zealand"},{"name":"Active Living and Rehabilitation: Aotearoa New Zealand Health and Rehabilitation Research Institute School of Clinical Sciences Auckland University of Technology  Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(23)01301\u20106"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.183"},{"key":"e_1_2_11_4_1","unstructured":"Shepard\u2010Wipiiti T. andL.Brennan.2021.The Economic and Social\u00a0Cost of Type 2 Diabetes [Research Report]. Aotearoa New Zealand."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214\u2010109X(20)30412\u20105"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615439"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2699"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci32169"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semvascsurg.2015.12.001"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13010"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3928\/01477447\u201020111021\u201016"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.04.011"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125\u2010012\u20102588\u2010z"},{"key":"e_1_2_11_14_1","unstructured":"Hall K.2021.Significant Rise in Amputations for Kiwis with Diabetes. 1NEWS (New Zealand).https:\/\/www.1news.co.nz\/2021\/11\/10\/significant\u2010rise\u2010in\u2010amputations\u2010for\u2010kiwis\u2010with\u2010diabetes\/."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2016.12.001"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13047\u2010018\u20100270\u20105"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcws.2009.05.003"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1533\/9780857093301.3.416"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0309364614534296"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011038.pub2"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3283"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.12968\/bjhc.2014.20.10.462"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17\u20101836"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102018\u2010028727"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3644"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/09593981003660222"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1086\/644732"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102648.2007.04569.x"},{"key":"e_1_2_11_30_1","unstructured":"29.Podiatrists Board of New Zealand Annual Report 1 April 2022\u201031 March 2023.2023."},{"key":"e_1_2_11_31_1","unstructured":"National Institute for Health and Care Excellent.2015.Type 2 Diabetes in Adults: Management. updated 2022.https:\/\/www.nice.org.uk\/guidance\/ng28."},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13047\u2010022\u201000534\u20107"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13047\u2010023\u201000651\u2010x"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13047\u2010015\u20100072\u2010y"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3657"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13047\u2010022\u201000544\u20105"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1575"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13047\u2010020\u201000430\u2010y"},{"key":"e_1_2_11_39_1","unstructured":"New Zealand Society for the Study of Diabetes.2017.Updated Foot Screening Referral Pathways."}],"container-title":["Journal of Foot and Ankle Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jfa2.12032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:12:00Z","timestamp":1719209520000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jfa2.12032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1002\/jfa2.12032"],"URL":"https:\/\/doi.org\/10.1002\/jfa2.12032","archive":["Portico"],"relation":{},"ISSN":["1757-1146","1757-1146"],"issn-type":[{"type":"print","value":"1757-1146"},{"type":"electronic","value":"1757-1146"}],"subject":[],"published":{"date-parts":[[2024,6]]},"article-number":"e12032"}}